For years, popular wisdom held that agile innovation and design thinking were uniquely challenging for life sciences companies. Indeed, healthcare organizations seemed to be watching from the sidelines as internet start-ups, as well as giants in IT, manufacturing and retail, leapt ahead in agile innovation strategies under rallying cries like “fail fast,” “build-measure-learn” and “minimally viable product.”
Yet healthcare organizations could quickly turn from laggards into leaders as pressure increases to become more nimble, respond to threats from outside disruptors and innovate more quickly on behalf of patients.
Read our new report - Biopharma Embraces Life in the Fast Lane - to find out how agile practices have the potential to solve some of pharma's biggest pain points.
